아이센스
099190KOSDAQ의료용 기기 제조업47.0 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Ai-Sensor is a company that develops, manufactures, and sells medical sensors and diagnostic equipment based on electrochemical and biosensor technologies. Its main business segments include blood glucose meters and point-of-care testing (POCT) devices. The blood glucose meter segment offers products with high accuracy and precision, while the CareSens Air continuous glucose monitoring system stands out with a competitive MARD value of 9%. The POCT segment provides a range of medical equipment, including electrolyte/gas analyzers and coagulation measurement devices.
Number of Employees
957people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
Well below industry avg
2.0x industry avg (risky)
Avg ▲9.9% (2-year basis)
Avg ▲60.5% (2-year basis)
Avg ROE -0.5% (declining, 3yr)
Detailed News Sentiment
- Neutral"AI 의료기기는 의약품 아니다…하이브리드 구조 위 작동돼야"
AI 의료기기 산업 활성화를 위한 포럼에서 AI 의료기기는 의약품이 아니라는 인식과 규제 합리화의 필요성이 논의되었습니다.
- Neutral'공매도 떨고있나' 이제는 코스닥 바이오의 시간
코스닥 바이오 기업들의 글로벌 성과 확산과 혁신 기술 부각으로 투자자들의 기대감이 높아지고 있다는 내용입니다.
Detailed Momentum
52w mid range (41%)
1m 1.27% (flat)
Volume flat
Detailed Disclosure
- Neutral정기주주총회결과2026-03-26
- Neutral사업보고서 (2025.12)2026-03-18
- Neutral감사보고서제출2026-03-18
